Foundation Medicine to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Foundation Medicine, Inc. (NASDAQ: FMI) today announced that members of the company's management team will present at the following upcoming investor conferences:

• Goldman Sachs Annual Healthcare Conference on Tuesday, June 13, 2017 at 11:20 a.m. P.T. in Rancho Palos Verdes, California.
• William Blair Growth Stock Conference on Thursday, June 15, 2017 at 8:40 a.m. C.T. in Chicago.

A live, listen-only webcast of the presentation may be accessed by visiting the investors section of the company’s website at investors.foundationmedicine.com. A replay of the webcast will be available shortly after the conclusion of each presentation and will be archived on the company's website for 90 days.

About Foundation Medicine

Foundation Medicine (NASDAQ: FMI) is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient’s unique cancer. The company offers a full suite of comprehensive genomic profiling assays to identify the molecular alterations in a patient’s cancer and match them with relevant targeted therapies, immunotherapies and clinical trials. Foundation Medicine's molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer. For more information, please visit http://www.FoundationMedicine.com or follow Foundation Medicine on Twitter (@FoundationATCG).

Foundation Medicine® is a registered trademark of Foundation Medicine, Inc.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170605005083/en/

Foundation Medicine, Inc.
Media Contact:
Lee-Ann Murphy, 617-245-3077
[email protected]
or
Investor Contact:
Kimberly Brown, 617-418-2215
[email protected]

Source: Foundation Medicine, Inc.

You May Also Be Interested In

• William Blair Upgrades Moderna (MRNA) to Outperform, 'we believe Moderna has a clear line of sight to revenue diversification from the COVID business
• FRACTAL Discloses Mesh-to-Gateway System for Part 15 D2D Satellite Connectivity
• OVBC announces extension of Stock Buyback Program